Automated, Real-Time Integration of Biometric Data From Wearable Devices With Electronic Medical Records: A Feasibility Study.

IF 3.3 Q2 ONCOLOGY JCO Clinical Cancer Informatics Pub Date : 2024-09-01 Epub Date: 2024-09-30 DOI:10.1200/CCI.24.00040
Julius K Weng, Ritupreet Virk, Kels Kaiser, Karen E Hoffman, Chelain R Goodman, Melissa Mitchell, Simona Shaitelman, Pamela Schlembach, Valerie Reed, Chi-Fang Wu, Lianchun Xiao, Grace L Smith, Benjamin D Smith
{"title":"Automated, Real-Time Integration of Biometric Data From Wearable Devices With Electronic Medical Records: A Feasibility Study.","authors":"Julius K Weng, Ritupreet Virk, Kels Kaiser, Karen E Hoffman, Chelain R Goodman, Melissa Mitchell, Simona Shaitelman, Pamela Schlembach, Valerie Reed, Chi-Fang Wu, Lianchun Xiao, Grace L Smith, Benjamin D Smith","doi":"10.1200/CCI.24.00040","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>A major barrier to the incorporation of biometric data into clinical practice is the lack of device integration with electronic medical records (EMRs). We developed infrastructure to transmit biometric data from an Apple Watch into the EMR for physician review. The study objective was to test feasibility of using this infrastructure for patients undergoing radiotherapy.</p><p><strong>Methods: </strong>The study included patients with breast or prostate cancer receiving ≥3 weeks of radiotherapy who reported owning an Apple Watch. Daily resting heart rate (HR), HR variability, step count, and exercise minutes were automatically transferred to our EMR using a custom app installed on each patient's iPhone. Biometric data were presented to the treating radiation oncologist for review on a weekly basis during creation of the on-treatment note. Feasibility was defined a priori as physician review of biometric data for at least 90% of patients. Time trends in biometric data were tested using the Jonckheere-Terpstra test. Patient satisfaction was assessed using the System Usability Scale (SUS), with scores above 80 considered above-average user experience.</p><p><strong>Results: </strong>Of the 20 patients enrolled, biometric data were successfully transmitted to the EMR and reviewed by the radiation oncologist for 95% (n = 19) of patients, thus meeting the a priori feasibility threshold. For patients with radiation courses ≥4 weeks, exercise minutes decreased over time (<i>P</i> = .01) and daily mean HR variability increased over time (<i>P</i> = .02). The median SUS was 82.5 (IQR, 70-87.5).</p><p><strong>Conclusion: </strong>Our study demonstrates the feasibility of real-time integration of biometric data collected from an Apple Watch into the EMR with subsequent physician review. The high rates of physician review and patient satisfaction provide support for further development of large-scale collection of wearable device data.</p>","PeriodicalId":51626,"journal":{"name":"JCO Clinical Cancer Informatics","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO Clinical Cancer Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1200/CCI.24.00040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: A major barrier to the incorporation of biometric data into clinical practice is the lack of device integration with electronic medical records (EMRs). We developed infrastructure to transmit biometric data from an Apple Watch into the EMR for physician review. The study objective was to test feasibility of using this infrastructure for patients undergoing radiotherapy.

Methods: The study included patients with breast or prostate cancer receiving ≥3 weeks of radiotherapy who reported owning an Apple Watch. Daily resting heart rate (HR), HR variability, step count, and exercise minutes were automatically transferred to our EMR using a custom app installed on each patient's iPhone. Biometric data were presented to the treating radiation oncologist for review on a weekly basis during creation of the on-treatment note. Feasibility was defined a priori as physician review of biometric data for at least 90% of patients. Time trends in biometric data were tested using the Jonckheere-Terpstra test. Patient satisfaction was assessed using the System Usability Scale (SUS), with scores above 80 considered above-average user experience.

Results: Of the 20 patients enrolled, biometric data were successfully transmitted to the EMR and reviewed by the radiation oncologist for 95% (n = 19) of patients, thus meeting the a priori feasibility threshold. For patients with radiation courses ≥4 weeks, exercise minutes decreased over time (P = .01) and daily mean HR variability increased over time (P = .02). The median SUS was 82.5 (IQR, 70-87.5).

Conclusion: Our study demonstrates the feasibility of real-time integration of biometric data collected from an Apple Watch into the EMR with subsequent physician review. The high rates of physician review and patient satisfaction provide support for further development of large-scale collection of wearable device data.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
将可穿戴设备的生物识别数据与电子病历进行自动、实时整合:可行性研究
目的:将生物识别数据纳入临床实践的一个主要障碍是设备与电子病历(EMR)缺乏集成。我们开发了将 Apple Watch 上的生物识别数据传输到 EMR 供医生审查的基础设施。研究目的是测试在接受放疗的患者中使用该基础设施的可行性:研究对象包括接受放疗时间≥3 周且报告拥有 Apple Watch 的乳腺癌或前列腺癌患者。使用安装在每位患者 iPhone 上的定制应用程序,每日静息心率 (HR)、心率变异性、步数和运动分钟数自动传输到我们的 EMR。生物计量数据每周在创建治疗记录时提交给放射肿瘤主治医师审核。可行性的先验定义是,至少有 90% 的患者的生物测定数据得到了医生的审核。生物测量数据的时间趋势使用 Jonckheere-Terpstra 检验进行测试。患者满意度采用系统可用性量表(SUS)进行评估,80 分以上视为用户体验高于平均水平:在登记的 20 名患者中,95%(n = 19)的患者的生物计量数据已成功传输到 EMR 并由放射肿瘤专家进行了审查,因此达到了先验可行性阈值。对于放射疗程≥4 周的患者,运动分钟数随时间推移而减少(P = .01),日平均心率变异性随时间推移而增加(P = .02)。中位 SUS 为 82.5(IQR,70-87.5):我们的研究证明了将从 Apple Watch 收集到的生物识别数据实时整合到 EMR 并由医生进行后续审查的可行性。医生审核率和患者满意度都很高,这为进一步发展大规模收集可穿戴设备数据提供了支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
4.80%
发文量
190
期刊最新文献
Identifying Oncology Patients at High Risk for Potentially Preventable Emergency Department Visits Using a Novel Definition. Use of Patient-Reported Outcomes in Risk Prediction Model Development to Support Cancer Care Delivery: A Scoping Review. Optimizing End Points for Phase III Cancer Trials. Patients Facing Large Language Models in Oncology: A Narrative Review. Informatics and Artificial Intelligence-Guided Assessment of the Regulatory and Translational Research Landscape of First-in-Class Oncology Drugs in the United States, 2018-2022.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1